Literature DB >> 12606689

Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.

Keith Williams1, Michael Dattilo, Thomas N Sabado, Keiko Kashiwagi, Kazuei Igarashi.   

Abstract

The properties of delta2 receptors, which have homology to glutamate receptors but are not gated by glutamate, were studied using the constitutively active Lurcher mutant delta2(A654T) expressed in Xenopus oocytes. The macroscopic current through delta2(A654T) channels in voltage-clamped oocytes was defined as the difference between the holding current measured in the presence of extracellular Na(+) and that in the presence of the large impermeant cation N-methyl-d-glucamine. A-to-T mutations in the delta1 subunit and in NMDA (N-methyl-d-aspartate) receptor subunits, at positions equivalent to delta2(A654T), did not produce constitutively active channels. The current through delta2(A654T) channels was reduced by pentamidine and 9-tetrahydroaminoacridine, antagonists that also inhibit NR1/NR2B NMDA receptors but not AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors. Block of delta2(A654T) currents by these two antagonists was incomplete and weakly voltage-dependent, in contrast to the block of NR1/NR2B receptors, which was complete and strongly voltage-dependent. Pentamidine inhibited a constitutively active NR1(T648A)/NR2B NMDA receptor in a manner similar to its inhibition of a glutamate-gated wild-type NMDA receptor, but different from its inhibition of constitutively active delta2(A654T) receptors. Currents gated by delta2(A654T) were sensitive to the extracellular pH, being smaller at acidic than at alkaline pH, with a pH IC(50) value of 7.47 and a maximum inhibition of 70%. It is concluded that delta2(A654T) channels have some properties in common with NMDA channels but also have characteristics that are different from these receptors. Compounds such as pentamidine may be useful for studies of native delta2 receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606689     DOI: 10.1124/jpet.102.045799

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  A domain linking the AMPA receptor agonist binding site to the ion pore controls gating and causes lurcher properties when mutated.

Authors:  Sabine M Schmid; Christoph Körber; Solveig Herrmann; Markus Werner; Michael Hollmann
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 3.  To gate or not to gate: are the delta subunits in the glutamate receptor family functional ion channels?

Authors:  Sabine M Schmid; Michael Hollmann
Journal:  Mol Neurobiol       Date:  2008-06-03       Impact factor: 5.590

Review 4.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

5.  The glutamate receptor subunit delta2 is capable of gating its intrinsic ion channel as revealed by ligand binding domain transplantation.

Authors:  Sabine M Schmid; Sabine Kott; Charlotte Sager; Thomas Huelsken; Michael Hollmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-08       Impact factor: 11.205

6.  Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors.

Authors:  Anders S Kristensen; Kasper B Hansen; Peter Naur; Lars Olsen; Natalie L Kurtkaya; Shashank M Dravid; Trine Kvist; Feng Yi; Jacob Pøhlsgaard; Rasmus P Clausen; Michael Gajhede; Jette S Kastrup; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-12-10       Impact factor: 4.436

7.  Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

Authors:  Lisa Sanderson; Marcelo da Silva; Gayathri N Sekhar; Rachel C Brown; Hollie Burrell-Saward; Mehmet Fidanboylu; Bo Liu; Lea Ann Dailey; Cécile A Dreiss; Chris Lorenz; Mark Christie; Shanta J Persaud; Vanessa Yardley; Simon L Croft; Margarita Valero; Sarah A Thomas
Journal:  PLoS Negl Trop Dis       Date:  2021-04-15

8.  The Hydrophobic Effect Contributes to the Closed State of a Simplified Ion Channel through a Conserved Hydrophobic Patch at the Pore-Helix Crossing.

Authors:  Michael Yonkunas; Maria Kurnikova
Journal:  Front Pharmacol       Date:  2015-11-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.